Bioceres Crop Solutions Corp [BIOX] stock is trading at $1.42, up 6.77%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BIOX shares have gain 8.40% over the last week, with a monthly amount drifted -31.07%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Bioceres Crop Solutions Corp [NASDAQ: BIOX] stock has seen the most recent analyst activity on September 10, 2025, when Canaccord Genuity downgraded its rating to a Hold but kept the price target unchanged to $2.50 for it. Oppenheimer started tracking the stock assigning an Outperform rating and suggested a price target of $15 on April 06, 2023. Canaccord Genuity initiated its recommendation with a Buy and recommended $22.50 as its price target on September 30, 2022. ROTH Capital started tracking with a Buy rating for this stock on October 08, 2021, and assigned it a price target of $21. In a note dated March 15, 2021, Lake Street initiated an Buy rating and provided a target price of $15 on this stock.
Bioceres Crop Solutions Corp [BIOX] stock has fluctuated between $1.20 and $7.80 over the past year. Currently, Wall Street analysts expect the stock to reach $4.17 within the next 12 months. Bioceres Crop Solutions Corp [NASDAQ: BIOX] shares were valued at $1.42 at the most recent close of the market. An investor can expect a potential return of 193.66% based on the average BIOX price forecast.
Analyzing the BIOX fundamentals
Bioceres Crop Solutions Corp [NASDAQ:BIOX] reported sales of 333.38M for the trailing twelve months, which represents a drop of -40.15%. Gross Profit Margin for this corporation currently stands at 0.39% with Operating Profit Margin at -0.01%, Pretax Profit Margin comes in at -0.16%, and Net Profit Margin reading is -0.15%. To continue investigating profitability, this company’s Return on Assets is posted at -0.06, Equity is -0.16 and Total Capital is -0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.89.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3350 points at the first support level, and at 1.2500 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.4700, and for the 2nd resistance point, it is at 1.5200.
Ratios To Look Out For
For context, Bioceres Crop Solutions Corp’s Current Ratio is 1.02. As well, the Quick Ratio is 0.72, while the Cash Ratio is 0.12. Considering the valuation of this stock, the price to sales ratio is 0.27, the price to book ratio is 0.29.
